Geneos Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$125K Sell
448
-35
-7% -$10.1K ﹤0.01% 1107
2025
Q4
$146K Buy
483
+467
+2,919% +$146K ﹤0.01% 1035
2025
Q3
$4.49K Sell
16
-126
-89% -$34.3K ﹤0.01% 2163
2025
Q2
$34.3K Sell
142
-25
-15% -$5.91K ﹤0.01% 1765
2025
Q1
$40.7K Buy
167
+121
+263% +$36.4K ﹤0.01% 2023
2024
Q4
$15.1K Buy
46
+3
+7% +$1.02K ﹤0.01% 1862
2024
Q3
$14.4K Buy
+43
New +$13.7K ﹤0.01% 1686
2022
Q1
Sell
-3
Closed -$2K 2762
2021
Q4
$2K Sell
3
-34
-92% -$25.4K ﹤0.01% 2562
2021
Q3
$27K Sell
37
-10
-21% -$7.49K ﹤0.01% 1765
2021
Q2
$31K Buy
47
+10
+27% +$6.09K ﹤0.01% 1696
2021
Q1
$23K Hold
37
﹤0.01% 1993
2020
Q4
$21K Buy
37
+34
+1,133% +$19.4K ﹤0.01% 1864
2020
Q3
$1K Hold
3
﹤0.01% 2489
2020
Q2
$1K Buy
+3
New +$1.32K ﹤0.01% 2425
2020
Q1
Sell
-3
Closed -$1K 2483
2019
Q4
$1K Hold
3
﹤0.01% 2435
2019
Q3
$1K Buy
+3
New +$979 ﹤0.01% 2367

Other funds holding BIO